Özlem Erçelep

570 total citations
55 papers, 366 citations indexed

About

Özlem Erçelep is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Özlem Erçelep has authored 55 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Özlem Erçelep's work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Özlem Erçelep is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Özlem Erçelep collaborates with scholars based in Türkiye, United Kingdom and Bahrain. Özlem Erçelep's co-authors include Perran Fulden Yumuk, Tuğba Akın Telli, Faysal Dane, Özkan Alan, Mahmut Gümüş, Melike Özçelik, Serap Kaya, Nalan Akgül Babacan, Mehmet Aliustaoğlu and Mehmet Akif Öztürk and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Özlem Erçelep

51 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özlem Erçelep Türkiye 12 175 145 72 64 44 55 366
Soojung Hong South Korea 13 292 1.7× 195 1.3× 101 1.4× 82 1.3× 43 1.0× 35 501
Luisa Santoro Italy 10 123 0.7× 89 0.6× 94 1.3× 48 0.8× 25 0.6× 32 347
Thomas Zaramboukas Greece 13 222 1.3× 124 0.9× 126 1.8× 131 2.0× 70 1.6× 34 467
Marco Carletto Italy 9 131 0.7× 126 0.9× 47 0.7× 80 1.3× 17 0.4× 13 334
Alper Can Türkiye 12 228 1.3× 146 1.0× 53 0.7× 37 0.6× 60 1.4× 29 338
Fazıl Aydin Türkiye 11 132 0.8× 88 0.6× 77 1.1× 69 1.1× 38 0.9× 32 345
Junichi Shiraishi Japan 11 183 1.0× 150 1.0× 121 1.7× 79 1.2× 18 0.4× 26 384
Stefano Margaritora Italy 13 175 1.0× 311 2.1× 129 1.8× 79 1.2× 43 1.0× 75 513
J. S. Lee South Korea 9 190 1.1× 215 1.5× 163 2.3× 49 0.8× 62 1.4× 17 392
Rashpal Flora United Kingdom 9 176 1.0× 184 1.3× 112 1.6× 52 0.8× 42 1.0× 17 468

Countries citing papers authored by Özlem Erçelep

Since Specialization
Citations

This map shows the geographic impact of Özlem Erçelep's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Erçelep with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Erçelep more than expected).

Fields of papers citing papers by Özlem Erçelep

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Erçelep. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Erçelep. The network helps show where Özlem Erçelep may publish in the future.

Co-authorship network of co-authors of Özlem Erçelep

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Erçelep. A scholar is included among the top collaborators of Özlem Erçelep based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Erçelep. Özlem Erçelep is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erçelep, Özlem, et al.. (2025). Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.. PubMed. 45(1). 18–24. 2 indexed citations
2.
Aksoy, Sercan, Burcu Çakar, Gül Başaran, et al.. (2023). Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers. 15(6). 1667–1667. 1 indexed citations
3.
Bayoğlu, İbrahim Vedat, Özlem Erçelep, Murat Sarı, et al.. (2023). PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score. Journal of Clinical Medicine. 12(19). 6420–6420.
4.
Telli, Tuğba Akın, Özkan Alan, Bülent Erol, et al.. (2022). Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma. Nutrition and Cancer. 74(7). 2499–2507. 1 indexed citations
5.
Telli, Tuğba Akın, İlker Tınay, Trevor Jones, et al.. (2022). Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters. Acta Radiologica. 64(5). 2040–2049. 2 indexed citations
6.
Telli, Tuğba Akın, Mehmet Akif Öztürk, Özkan Alan, et al.. (2022). Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy. Future Oncology. 18(22). 2425–2439.
7.
Telli, Tuğba Akın, Özkan Alan, Bülent Erol, et al.. (2022). Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities. Orthopaedics & Traumatology Surgery & Research. 109(3). 103491–103491. 1 indexed citations
8.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2022). Impact of prognostic nutritional index on survival in recurrent glioblastoma. PubMed. 33(1). 15–21. 3 indexed citations
9.
Telli, Tuğba Akın, et al.. (2020). QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer. Current Problems in Cancer. 44(6). 100594–100594. 4 indexed citations
10.
Erçelep, Özlem, et al.. (2020). Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer. Journal of Turkish Society of Obstetric and Gynecology. 17(2). 123–127. 1 indexed citations
11.
Telli, Tuğba Akın, et al.. (2020). A rare case of gastric cancer with bilateral breast metastasis during pregnancy. Journal of Oncology Pharmacy Practice. 27(1). 220–226. 5 indexed citations
12.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment. Clinical Neurology and Neurosurgery. 196. 105976–105976. 4 indexed citations
13.
Erçelep, Özlem, Özkan Alan, Tuğba Akın Telli, et al.. (2020). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal. 107(3). 231–237. 5 indexed citations
14.
Telli, Tuğba Akın, et al.. (2020). Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. Current Problems in Cancer. 45(2). 100668–100668. 7 indexed citations
15.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice. 27(2). 329–339. 2 indexed citations
16.
Telli, Tuğba Akın, İlker Ökten, Özkan Alan, et al.. (2020). VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature. Current Problems in Cancer. 44(5). 100568–100568. 11 indexed citations
17.
Oruç, Zeynep, Kaplan Ma, Çağlayan Geredeli, et al.. (2020). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.. PubMed. 24(2). 1876–1883. 2 indexed citations
18.
Erçelep, Özlem, Nuriye Özdemir, Nedim Turan, et al.. (2018). Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas. Current Problems in Cancer. 43(1). 27–32. 7 indexed citations
19.
Şendur, Mehmet Alı Nahıt, Umut Kefeli, Bala Başak Öven Ustaalıoğlu, et al.. (2016). Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clinical Colorectal Cancer. 16(1). 78–83. 17 indexed citations
20.
Kefeli, Umut, Nurgül Yaşar, Özlem Erçelep, et al.. (2012). Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers. 17(7). 663–667. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soojung Hong Breakdown of academic impact, for papers by Luisa Santoro Breakdown of academic impact, for papers by Thomas Zaramboukas Breakdown of academic impact, for papers by Marco Carletto Breakdown of academic impact, for papers by Alper Can Breakdown of academic impact, for papers by Fazıl Aydin Breakdown of academic impact, for papers by Junichi Shiraishi Breakdown of academic impact, for papers by Stefano Margaritora Breakdown of academic impact, for papers by J. S. Lee Breakdown of academic impact, for papers by Rashpal Flora
Rankless by CCL
2026